Spotlight on Anti‐CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 534, doi. 10.1002/cpdd.345
- By:
- Publication type:
- Article
Works matching IS 2160763X AND DT 2017 AND VI 6 AND IP 6
Results: 13
1
2
Some Methodologic Considerations in the Assessment of Methods for Predicting Pharmacokinetic Drug‐Drug Interactions.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 529, doi. 10.1002/cpdd.373
- By:
- Publication type:
- Article
3
Safety, Tolerability, and Antihypertensive Effect of SER100, an Opiate Receptor‐Like 1 (ORL‐1) Partial Agonist, in Patients With Isolated Systolic Hypertension.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 584, doi. 10.1002/cpdd.330
- By:
- Publication type:
- Article
4
LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose Levels.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 556, doi. 10.1002/cpdd.392
- By:
- Publication type:
- Article
5
Safety, Tolerability, and Pharmacokinetics of Therapeutic and Supratherapeutic Doses of Tramadol Hydrochloride in Healthy Adults: A Randomized, Double‐Blind, Placebo‐Controlled Multiple‐Ascending‐Dose Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 592, doi. 10.1002/cpdd.378
- By:
- Publication type:
- Article
6
Evaluation of Potential Drug–Drug Interaction Between Delayed‐Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Healthy Women.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 604, doi. 10.1002/cpdd.377
- By:
- Publication type:
- Article
7
Absolute Bioavailability and Pharmacokinetic Comparability of Sirukumab Following Subcutaneous Administration by a Prefilled Syringe or an Autoinjector.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 570, doi. 10.1002/cpdd.328
- By:
- Publication type:
- Article
8
Impact of Acid‐Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH‐Dependent Solubility, With Different Food Intake Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 614, doi. 10.1002/cpdd.356
- By:
- Publication type:
- Article
9
A Randomized, Placebo‐ and Positive‐Controlled, Single‐Dose, Crossover Thorough QT/QTc Study Assessing the Effect of Daprodustat on Cardiac Repolarization in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 627, doi. 10.1002/cpdd.342
- By:
- Publication type:
- Article
10
The Effect of Verapamil, a P‐Glycoprotein Inhibitor, on the Pharmacokinetics of Peficitinib, an Orally Administered, Once‐Daily JAK Inhibitor.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 548, doi. 10.1002/cpdd.344
- By:
- Publication type:
- Article
11
Relative Bioavailability of a Dolutegravir Dispersible Tablet and the Effects of Low‐ and High‐Mineral‐Content Water on the Tablet in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 577, doi. 10.1002/cpdd.332
- By:
- Publication type:
- Article
12
Lornoxicam Immediate‐Release Tablets: Formulation and Bioequivalence Study in Healthy Mediterranean Volunteers Using a Validated LC‐MS/MS Method.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 564, doi. 10.1002/cpdd.333
- By:
- Publication type:
- Article
13
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 525, doi. 10.1002/cpdd.305
- Publication type:
- Article